ERBB2 and neoplasm: Therefore, the osteolytic MRMT-1 breast-derived bone metastasis consists of ERα (+), HER2 (−), Ki-67 (+) tumor cells, which can be classified as a luminal B invasive adenocarcinoma40,41.